Adverum Biotechnologies, Inc. Human Resources Contracts & Agreements
77 Contracts & Agreements
- Bonus & Incentive Agreements (13 contracts)
- Change of Control Agreements (20)
- Compensation Agreements (7)
- Confidentiality Agreements (2)
- Consulting Agreements (10)
- Employment Agreements (14)
- Separation Agreements (11)
- Non-Employee Director Compensation Policy (Filed With SEC on August 12, 2024)
- Form of Change in Control and Severance Agreement for executive officers other than the chief executive officer (Filed With SEC on August 10, 2023)
- Employment Offer Letter between Adverum Biotechnologies, Inc. and Linda Rubinstein, dated as of August 3, 2023 (Filed With SEC on August 10, 2023)
- Consulting Agreement between Adverum Biotechnologies, Inc. and Richard Beckman, M.D., dated as of June 1, 2023 (Filed With SEC on August 10, 2023)
- Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Richard Beckman, M.D., dated as of May 24, 2023 (Filed With SEC on August 10, 2023)
- Confidential Consulting Agreement between Adverum Biotechnologies, Inc. and FLG Partners, LLC, dated as of November 22, 2022 (Filed With SEC on March 30, 2023)
- Consulting Agreement between Adverum Biotechnologies, Inc. and Nancy E. Pecota, dated as of June 29, 2022 (Filed With SEC on August 11, 2022)
- Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Rupert D'Souza, dated as of June 7, 2022 (Filed With SEC on August 11, 2022)
- Employment Agreement between Adverum Biotechnologies, Inc. and John Rakow, dated as of January 2 (Filed With SEC on August 11, 2022)
- Employment Agreement (Filed With SEC on March 29, 2022)
- Employment Agreement (Filed With SEC on March 29, 2022)
- Employment Agreement between Adverum Biotechnologies, Inc. and Rupert D'Souza, dated as of November 12, 2021 (Filed With SEC on March 29, 2022)
- Employment Agreement between Adverum Biotechnologies, Inc. and Brigit Riley, dated as of May 21, 2021 (Filed With SEC on March 29, 2022)
- Form of Change in Control (Filed With SEC on March 29, 2022)
- Form of Performance Stock Unit Award Grant Notice and Performance Stock Unit Award Agreement under the 2014 Equity Incentive Award Plan (Filed With SEC on March 29, 2022)
- Consulting Agreement between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021 (Filed With SEC on November 4, 2021)
- Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021 (Filed With SEC on November 4, 2021)
- Change in Control and Severance Agreement with Chris DeRespino, dated February 1, 2021 (Filed With SEC on August 5, 2021)
- Employment Offer Letter with Chris DeRespino, dated February 1, 2021 (Filed With SEC on August 5, 2021)
- Change in Control and Severance Agreement with Julie Clark, dated May 25, 2021 (Filed With SEC on August 5, 2021)
- Employment Offer Letter with Julie Clark, dated April 2, 2020 (Filed With SEC on August 5, 2021)
- Consulting Agreement between Adverum Biotechnologies, Inc. and Leone Patterson, dated June 24, 2021 (Filed With SEC on August 5, 2021)
- Non-Employee Director Compensation Policy, effective May 5, 2021 (Filed With SEC on May 6, 2021)
- Non-Employee Director Compensation Policy, effective March 31, 2021 (Filed With SEC on May 6, 2021)
- Consulting Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021 (Filed With SEC on May 6, 2021)
- Separation Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021 (Filed With SEC on May 6, 2021)
- Consulting Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated March 18, 2021 (Filed With SEC on May 6, 2021)
- Separation Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated April 7, 2021 (Filed With SEC on May 6, 2021)
- Adverum Biotechnologies, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on August 10, 2020)
- Adverum Biotechnologies, Inc. Amended and Restated 2006 Equity Incentive Plan (Filed With SEC on August 10, 2020)
- Amended and Restated Non-Employee Director Compensation Policy, effective June 22, 2020 (Filed With SEC on August 10, 2020)
- Amended and Restated Change in Control and Severance Agreement with Leone Patterson, dated (Filed With SEC on August 10, 2020)
- Amended and Restated Change in Control and Severance Agreement with Leone Patterson, dated (Filed With SEC on August 10, 2020)
- Change in Control and Severance Agreement Laurent Fischer, dated (Filed With SEC on August 10, 2020)
- Employment Offer Letter with Laurent Fischer, dated (Filed With SEC on August 10, 2020)
- Employment Agreement, dated (Filed With SEC on May 28, 2020)
- Non-Employee Director Compensation Policy, effective December 13, 2019 (Filed With SEC on March 12, 2020)
- Non-Employee Director Compensation Policy, effective August 15, 2019 (Filed With SEC on November 7, 2019)
- Separation Letter and Consulting Agreement, dated September 3, 2019 and September 6, 2019, respectively, between Adverum Biotechnologies, Inc. and Jennifer Cheng (Filed With SEC on November 7, 2019)
- Separation and Consulting Agreement, dated July 31, 2019, between Adverum Biotechnologies, Inc. and Mehdi Gasmi (Filed With SEC on November 7, 2019)
